API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 134 articles Forum Github 13 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. ELVN.NASDAQ

Enliven Therapeutics Inc. (ELVN NASDAQ) stock market data APIs

$22.92 -0.27(-1.2%) as of September 20, 2024
Price chart is built with Anychart

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. The company is headquartered in Boulder, Colorado.

Enliven Therapeutics Inc. Financial Data Overview

23.19
22.92
-
23.55
22.39
9.8-27.6731
1 090 M
47 237 K
0
-0.41
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ELVN',
Type: 'Common Stock',
Name: 'Enliven Therapeutics Inc.',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00CP3BDD4',
ISIN: NULL,
CUSIP: NULL,
CIK: '1672619',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-03-12',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Enliven Therapeutics Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -95 954 000
  • Earnings Per Share -1.91
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Enliven Therapeutics Inc. Earnings via APIs

  • Latest Release 2024-08-13
  • EPS/Forecast -0.55

Get Enliven Therapeutics Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Enliven Therapeutics Inc. latest news via APIs

Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst

Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst HC Wainwright initiated coverage on Enliven Therapeutics, Inc. (NASDAQ:ELVN) and noted t...

Enliven Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update

Company on track to deliver initial proof of concept data for ELVN-001 and ELVN-002 in 2024 Strong balance sheet, closing the quarter with $263 million in cash, cash equivalents and marketable securi...
  • CONFERENCE CALLS/ WEBCASTS
  • EARNINGS RELEASES AND OPERATING RESULTS
  • ENLIVEN THERAPEUTICS
  • INC
  • NASDAQ:ELVN
Do you have any questions?
support@eodhistoricaldata.com